Vaccine bottle being filled

Covid-19 vaccine approved for use in the UK

The UK could soon see the first Covid-19 vaccines rolled out to priority groups after the Government accepted a recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to approve the Pfizer vaccine candidate for use.

Months of rigorous clinical trials were carried out as standard by the vaccine manufacturers, with a thorough analysis of the data being undertaken by experts at the MHRA to ensure it met strict standards of safety, quality and effectiveness before it could be approved.

The UK becomes the first country in the world to approve the use of this particular vaccine, which had proven around 90% effective against the virus, according to preliminary data.

It will now be able to be administered to the first people in the UK, who are expected to be a number of priority groups including care home residents, health and care staff, the elderly and the clinically extremely vulnerable.

The UK has already secured 40 million doses of the vaccine – enough to vaccinate approximately 20 million people – with around 10 million doses due to be available soon. The first 800,000 doses are due to arrive in the coming days.

A Department of Health and Social Care spokesperson said: “The Government has today accepted the recommendation from the independent Medicines and Healthcare products Regulatory Agency (MHRA) to approve Pfizer-BioNTech’s Covid-19 vaccine for use.

““The Joint Committee on Vaccinations and Immunisations (JCVI) will shortly publish its final advice for the priority groups to receive the vaccine.

“The vaccine will be made available across the UK from next week.

“The NHS has decades of experience in delivering large scale vaccination programmes and will begin putting their extensive preparations into action to provide care and support to all those eligible for vaccination.

“To aid the success of the vaccination programme it is vital everyone continues to play their part and abide by the necessary restrictions in their area so we can further suppress the virus and allow the NHS to do its work without being overwhelmed.”

NHE Sept/Oct 21

NHE Sept/Oct 21

Improving care for long-term conditions

Join us in our September/October edition of National Health Executive, as we explore a range of topics impacting and improving the care that we can deliver to patients, the facilities within which we deliver them, and the opportunities in the digital space to accent and evolve our care capabilities


View all videos
National Health Executive Presents

National Health Executive Presents

NHE365 Virtual Festival: Digital Healthcare

The integration of new technology, such as using virtual outpatient appointments instead of face-to-face reviews of patients in the hospital. Adapting the ways in which our NHS workers serve people has been critical in continuing to provide high-quality treatment, a positive patient experience and preventing Covid-19 transmission during the pandemic. Our healthcare sector has the potential to transform the way we continue to provide essential services while also improving patient care. But how easy is the integration of these innovations into routine NHS practice?

On the 28th of October, at the NHE365 Virtual Hospitals & Technology Enabled Care online event, we will be discussing patient flow and experience, reducing waiting times, reducing the patient backlog and increasing technology adoption. Will you be attending? 

Finger on the Pulse

Ep 14. Health messaging is a science, Professor Craig Jackson

On Episode 14 of NHE's Finger on the Pulse podcast, we're joined by Professor Craig Jackson, Professor of Occupational Health Psychology
Birmingham City University to discuss the coronavirus pandemic, the health messaging around it and how those in power have missed a trick by overlooking the key role of psychology in informing the public of restrictions, measures and the ever-changing situation

More articles...

View all